会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Implantable cardioverter defibrillator having a smaller displacement
volume
    • 具有较小排量的植入式心律转复除颤器
    • US5405363A
    • 1995-04-11
    • US263257
    • 1994-06-21
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • A61N1/375A61N1/378A61N1/39H01M2/10H01M6/50H01M16/00
    • A61N1/375A61N1/3787A61N1/3931A61N1/3956A61N1/3975H01M16/00A61N1/3758A61N1/3906A61N1/3912H01M2/1066H01M6/5016
    • A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller displacement volume of less than about 90 cc. The smaller volume of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.c, as well as corollary decreases in the effective capacitance value required for the capacitor and the net energy storage required of the battery, the overall displacement volume of the ICD is reduced to the point where subcutaneous implantation of the device in the pectoral region of human patients is practical. The size of the capacitor is reduced because the effective capacitance required can be less than about 125 .mu. F. By optimizing both the charging time and the countershock duration for the smaller maximum E.sub.c, the size of the battery is reduced because the total energy storage capacity can be less than about 1.0 Amp-hours. In the preferred embodiment, the charging time for each defibrillation countershock is reduced to less than about 10 seconds and the pulse duration of the countershock is reduced to less than about 6 milliseconds.
    • 电容放电可植入式心律转复除颤器(ICD)具有小于约90cc的相对较小的置换体积。 通过选择和布置ICD的内部部件来实现ICD的体积较小,以提供根据最小生理有效电流(Ipe)而不是最小除颤阈值能量(DFT)优化的最大除颤反相。 作为最小有效电流Ipe优化的结果,ICD的电容器必须存储的最大电荷能量(Ec)显着降低到小于约30焦耳,即使较高的 设备提供安全余量。 由于最大Ec的这种减小以及电容器所需的有效电容值和电池所需的净能量存储的必然减小,ICD的总位移体积减少到皮下植入 在人类胸腔的器官是实用的。 电容器的尺寸减小,因为所需的有效电容可以小于约125μF。通过优化较小的最大Ec的充电时间和反冲时间,电池的尺寸减小,因为总能量存储容量 可以小于约1.0安培小时。 在优选实施例中,每个去纤维颤动反射的充电时间减少到小于约10秒,并且该反冲的脉冲持续时间减小到小于约6毫秒。
    • 4. 发明授权
    • Implantable cardioverter defibrillator having a smaller displacement
volume
    • 具有较小排量的植入式心律转复除颤器
    • US5697953A
    • 1997-12-16
    • US582529
    • 1996-01-11
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • A61N1/375A61N1/39H01M2/10H01M6/50H01M16/00
    • A61N1/375A61N1/3956A61N1/3758H01M16/00H01M2/1066H01M6/5016
    • A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively longer device life of greater that 5 years. The longer life of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.c, as well as corollary decreases in the effective capacitance value required for the capacitor and the net energy storage required of the battery, the overall displacement volume of the ICD is reduced to the point where subcutaneous implantation of the device in the pectoral region of human patients is practical. The size of the capacitor is reduced because the effective capacitance required can be less than about 125 .mu.F. By optimizing both the charging time and the countershock duration for the smaller maximum E.sub.c, the size of the battery is reduced because the total energy storage capacity can be less than about 1.0 Amp-hours. In the preferred embodiment, the charging time for each defibrillation countershock is reduced to less than about 10 seconds and the pulse duration of the countershock is reduced to less than about 6 milliseconds.
    • 电容放电可植入式心律转复除颤器(ICD)具有相对较长的器件寿命,大于5年。 通过选择和布置ICD的内部组件来实现ICD的更长寿命,以提供根据最小生理有效电流(Ipe)而不是最小除颤阈值能量(DFT)优化的最大除颤抗倒伏。 作为最小有效电流Ipe优化的结果,ICD的电容器必须存储的最大电荷能量(Ec)显着降低到小于约30焦耳,即使较高的 设备提供安全余量。 由于最大Ec的这种减小以及电容器所需的有效电容值和电池所需的净能量存储的必然减小,ICD的总位移体积减少到皮下植入 在人类胸腔的器官是实用的。 电容器的尺寸减小,因为所需的有效电容可以小于约125μF。通过优化较小的最大Ec的充电时间和反冲时间,电池的尺寸减小,因为总能量存储容量 可以小于约1.0安培小时。 在优选实施例中,每个去纤维颤动反射的充电时间减少到小于约10秒,并且该反冲的脉冲持续时间减小到小于约6毫秒。
    • 5. 发明授权
    • Optimal pulse defibrillator
    • 最佳脉搏除颤器
    • US5645573A
    • 1997-07-08
    • US478001
    • 1995-06-07
    • Mark W. KrollCharles U. Smith
    • Mark W. KrollCharles U. Smith
    • A61N1/39
    • A61N1/3956A61N1/3906A61N1/3912
    • The model that is developed in the present invention is based upon the pioneering neurophysiological models of Lapicque and Weiss. The present model determines mathematically the optimum pulse duration, d.sub.p, for a truncated capacitor-discharge waveform employed for defibrillation. The model comprehends the system time constant, RC, where R is tissue resistance and C is the value of the capacitor being discharged, and also the chronaxie time, d.sub.c, defined by Lapicque, which is a characteristic time associated with the heart. The present model and analysis find the optimum pulse duration to be d.sub.p =(0.58)(RC+d.sub.c). Taking the best estimate of the chronaxie value from the literature to be 2.7 ms, permits one to rewrite the optimum pulse duration as d.sub.p =(0.58)RC+1.6 ms. The present invention makes use of the mathematical definition of optimum pulse duration by storing in the control circuitry of the defibrillation system the actual measured value of the particular capacitor incorporated in the system. The optimized-pulse prescription of this invention can be applied to a monophasic waveform, or to either or both of the phases of a biphasic waveform.
    • 本发明开发的模型是基于Lapicque和Weiss的开创性神经生理学模型。 本模型在数学上确定了用于除颤的截断电容放电波形的最佳脉冲持续时间dp。 该模型包括系统时间常数RC,其中R是组织电阻,C是正在放电的电容器的值,以及由与心脏相关联的特征时间Lapicque定义的时间曲线dc。 目前的模型和分析发现最佳脉冲持续时间为dp =(0.58)(RC + dc)。 将文献中的时代值的最佳估计值设为2.7 ms,可以将最优脉冲持续时间重写为dp =(0.58)RC + 1.6 ms。 本发明通过在除颤系统的控制电路中存储包含在系统中的特定电容器的实际测量值来利用最佳脉冲持续时间的数学定义。 本发明的优化脉冲处方可以应用于单相波形,也可以应用于双相波形的任一相或两相。
    • 6. 发明授权
    • Implantable cardioverter defibrillator having a smaller mass
    • 植入式心律转复除颤器质量较小
    • US5957956A
    • 1999-09-28
    • US963154
    • 1997-11-03
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • A61N1/375A61N1/39H01M2/10H01M6/50H01M16/00A61N1/18
    • A61N1/375A61N1/3956A61N1/3758H01M16/00H01M2/1066H01M6/5016
    • A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller mass of less than about 120 grams. The smaller mass of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.c, as well as corollary decreases in the effective capacitance value required for the capacitor and the net energy storage required of the battery, the overall displacement volume of the ICD is reduced to the point where subcutaneous implantation of the device in the pectoral region of human patients is practical. The size of the capacitor is reduced because the effective capacitance required can be less than about 125 .mu.F. By optimizing both the charging time and the countershock duration for the smaller maximum E.sub.c, the size of the battery is reduced because the total energy storage capacity can be less than about 1.0 Amp-hours. In the preferred embodiment, the charging time for each defibrillation countershock is reduced to less than about 10 seconds and the pulse duration of the countershock is reduced to less than about 6 milliseconds.
    • 电容放电植入式心律转复除颤器(ICD)的质量相对较小,小于约120克。 通过选择和布置ICD的内部部件来实现ICD的较小质量,以提供根据最小生理有效电流(Ipe)而不是最小除颤阈值能量(DFT)优化的最大除颤抗倒伏。 作为最小有效电流Ipe优化的结果,ICD的电容器必须存储的最大电荷能量(Ec)显着降低到小于约30焦耳,即使较高的 设备提供安全余量。 由于最大Ec的这种减小以及电容器所需的有效电容值和电池所需的净能量存储的必然减小,ICD的总位移体积减少到皮下植入 在人类胸腔的器官是实用的。 电容器的尺寸减小,因为所需的有效电容可以小于约125μF。通过优化较小的最大Ec的充电时间和反冲时间,电池的尺寸减小,因为总能量存储容量 可以小于约1.0安培小时。 在优选实施例中,每个去纤维颤动反射的充电时间减少到小于约10秒,并且该反冲的脉冲持续时间减小到小于约6毫秒。
    • 7. 发明授权
    • Implantable cardioverter defibrillator having a smaller energy storage
capacity
    • 具有较小能量储存能力的植入式心律转复除颤器
    • US5827326A
    • 1998-10-27
    • US412920
    • 1995-03-29
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • Mark W. KrollTheodore P. AdamsKenneth M. AndersonCharles U. Smith
    • A61N1/375A61N1/378A61N1/39H01M2/10H01M6/50H01M16/00
    • A61N1/375A61N1/3787A61N1/3931A61N1/3956A61N1/3975H01M16/00A61N1/3758A61N1/3906A61N1/3912H01M2/1066H01M6/5016
    • A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller energy storage capacity of less than about 1.0 Amp-hours. The smaller energy storage capacity of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe) rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.c, as well as corollary decreases in the effective capacitance value required for the capacitor and the net energy storage required of the battery, the overall displacement volume of the ICD is reduced to the point where subcutaneous implantation of the device in the pectoral region of human patients is practical. The size of the capacitor is reduced because the effective capacitance required can be less than about 125 .mu.F. By optimizing both the charging time and the countershock duration for the smaller maximum E.sub.c, the size of the battery is reduced because the total energy storage capacity can be less than about 1.0 Amp-hours. In the preferred embodiment, the charging time for each defibrillation countershock is reduced to less than about 10 seconds and the pulse duration of the countershock is reduced to less than about 6 milliseconds.
    • 电容放电植入式心律转复除颤器(ICD)具有小于约1.0安培小时的相对较小的储能能力。 通过选择和布置ICD的内部部件来实现ICD的较小的能量存储容量,以提供根据最小生理有效电流(Ipe)而不是最小除颤阈值能量(DFT)优化的最大除颤反相。 作为最小有效电流Ipe优化的结果,ICD的电容器必须存储的最大电荷能量(Ec)显着降低到小于约30焦耳,即使较高的 设备提供安全余量。 由于最大Ec的这种减小以及电容器所需的有效电容值和电池所需的净能量存储的必然减小,ICD的总位移体积减少到皮下植入 在人类胸腔的器官是实用的。 电容器的尺寸减小,因为所需的有效电容可以小于约125μF。通过优化较小的最大Ec的充电时间和反冲时间,电池的尺寸减小,因为总能量存储容量 可以小于约1.0安培小时。 在优选实施例中,每个去纤维颤动反射的充电时间减少到小于约10秒,并且该反冲的脉冲持续时间减小到小于约6毫秒。
    • 8. 发明授权
    • Optimal pulse defibrillator
    • 最佳脉搏除颤器
    • US5549643A
    • 1996-08-27
    • US322189
    • 1994-10-12
    • Mark W. KrollCharles U. Smith
    • Mark W. KrollCharles U. Smith
    • A61N1/39H01M2/10H01M16/00
    • A61N1/3956A61N1/3906A61N1/3912H01M16/00H01M2/1066
    • The model that is developed in the invention is based upon the pioneering neurophysiological models of Lapicque and Weiss. The present model determines mathematically the optimum pulse duration, d.sub.p, for a truncated capacitor-discharge waveform employed for defibrillation. The model comprehends the system time constant, RC, where R is tissue resistance and C is the value of the capacitor being discharged, and also the chronaxie time, d.sub.c, defined by Lapicque, which is a characteristic time associated with the heart. The present model and analysis find the optimum pulse duration to be d.sub.p =(0.58)(RC+d.sub.c). Taking the best estimate of the chronaxie value from the literature to be 2.7 ms, permits one to rewrite the optimum pulse duration as d.sub.p =(0.58)RC+1.6 ms. The apparatus makes use of the mathematical definition of optimum pulse duration by storing in the control circuitry of the defibrillation system the actual measured value of the particular capacitor incorporated in the system. The optimized-pulse prescription of this invention can be applied to a monophasic waveform, or to either or both of the phases of a biphasic waveform.
    • 本发明开发的模型是基于Lapicque和Weiss的开创性神经生理学模型。 本模型在数学上确定了用于除颤的截断电容放电波形的最佳脉冲持续时间dp。 该模型包括系统时间常数RC,其中R是组织电阻,C是正在放电的电容器的值,以及由与心脏相关联的特征时间Lapicque定义的时间曲线dc。 目前的模型和分析发现最佳脉冲持续时间为dp =(0.58)(RC + dc)。 将文献中的时代值的最佳估计值设为2.7 ms,可以将最优脉冲持续时间重写为dp =(0.58)RC + 1.6 ms。 该装置通过在除颤系统的控制电路中存储包含在系统中的特定电容器的实际测量值来利用最佳脉冲持续时间的数学定义。 本发明的优化脉冲处方可以应用于单相波形,也可以应用于双相波形的任一相或两相。
    • 9. 发明授权
    • Method for optimal pulse defibrillation using an implantable
defibrillator
    • 使用可植入除颤器进行最佳脉搏除颤的方法
    • US5431686A
    • 1995-07-11
    • US835836
    • 1992-02-18
    • Mark W. KrollCharles U. Smith
    • Mark W. KrollCharles U. Smith
    • A61N1/39H01M2/10H01M16/00A61N1/00
    • A61N1/3956A61N1/3906A61N1/3912H01M16/00H01M2/1066
    • The model that is developed in the present invention is based upon the pioneering neurophysiological models of Lapicque and Weiss. The present model determines mathematically the optimum pulse duration, d.sub.p, for a truncated capacitor-discharge waveform employed for defibrillation. The model comprehends the system time constant, RC, where R is tissue resistance and C is the value of the capacitor being discharged, and also the chronaxie time, d.sub.c, defined by Lapicque, which is a characteristic time associated with the heart. The present model and analysis find the optimum pulse duration to be d.sub.p =(0.58)(RC+d.sub.c). Taking the best estimate of the chronaxie value from the literature to be 2.7 ms, permits one to rewrite the optimum pulse duration as d.sub.p =(0.58)RC+1.6 ms. The present invention makes use of the mathematical definition of optimum pulse duration by storing in the control circuitry of the defibrillation system the actual measured value of the particular capacitor incorporated in the system. The optimized-pulse prescription of this invention can be applied to a monophasic waveform, or to either or both of the phases of a biphasic waveform.
    • 本发明开发的模型是基于Lapicque和Weiss的开创性神经生理学模型。 本模型在数学上确定了用于除颤的截断电容放电波形的最佳脉冲持续时间dp。 该模型包括系统时间常数RC,其中R是组织电阻,C是正在放电的电容器的值,以及由与心脏相关联的特征时间Lapicque定义的时间曲线dc。 目前的模型和分析发现最佳脉冲持续时间为dp =(0.58)(RC + dc)。 将文献中的时代值的最佳估计值设为2.7 ms,可以将最优脉冲持续时间重写为dp =(0.58)RC + 1.6 ms。 本发明通过在除颤系统的控制电路中存储包含在系统中的特定电容器的实际测量值来利用最佳脉冲持续时间的数学定义。 本发明的优化脉冲处方可以应用于单相波形,也可以应用于双相波形的任一相或两相。